Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AIM: Amoxicillin for Chronic Low Back Pain with Modic Changes
NCT02323412Phase 3Completed
- Sponsor
- Oslo University Hospital
- Start
- Jun 2015
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic low back pain (CLBP) comparing Amoxicillin with Placebo (2 arms). Primary endpoint: Roland Morris Disability Questionnaire at 12 months. Started Jun 2015; status: completed.
02
Drugs
amoxicillin
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT02323412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02323412.